N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate
C42H47Cl2F2N11O5S — CID 158037392
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate
N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate (PubChem CID 158037392) has the molecular formula C42H47Cl2F2N11O5S and a molecular weight of 926.88 g/mol. Its IUPAC name is N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate.
Molecular Properties
| Compound Name | N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate |
|---|---|
| PubChem CID | 158037392 |
| Molecular Formula | C42H47Cl2F2N11O5S |
| Molecular Weight | 926.88 g/mol |
| Exact Mass | 925.28 |
| IUPAC Name | N-[3-[[2-(5-chloro-1H-indol-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide;oxolan-3-ylmethyl N-[(1R,3S)-3-[[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate |
| SMILES | CS(=O)(=O)NC1CCCC(Nc2nc(-c3c[nH]c4ccc(Cl)cc34)ncc2F)C1.O=C(N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1)OCC1CCOC1 |
| InChI | InChI=1S/C23H26ClFN6O3.C19H21ClFN5O2S/c24-14-6-17-18(9-27-20(17)26-8-14)21-28-10-19(25)22(31-21)29-15-2-1-3-16(7-15)30-23(32)34-12-13-4-5-33-11-13;1-29(27,28)26-13-4-2-3-12(8-13)24-19-16(21)10-23-18(25-19)15-9-22-17-6-5-11(20)7-14(15)17/h6,8-10,13,15-16H,1-5,7,11-12H2,(H,26,27)(H,30,32)(H,28,29,31);5-7,9-10,12-13,22,26H,2-4,8H2,1H3,(H,23,24,25)/t13?,15-,16+;/m0./s1 |
| InChIKey | FHXPUJYOGIMUAB-RZFYBLOTSA-N |
| XLogP | 7.99 |
| TPSA | 213.82 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 926.88 |
| LogP ≤ 5 | 7.99 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158037392 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.